University Memory and Cognition Center, Case Western Reserve University, Cleveland, Ohio, USA; Department of Neurodegenerative Diseases Institute of Agricultural Medicine, Lublin, Poland
CORRESPONDING AUTHOR
Katarzyna Gustaw-Rothenberg
MD, PhD, Department of
Neurodegenerative Diseases, Institute of Agricultural Medicine, Jaczewskiego 2,
20-090 Lublin, Poland.
There is much data concerning ApoE in the pathology of Alzheimer’s disease. This study examines how ApoE genotype contributes to a risk for Alzheimer’s disease in the population of the Lublin region in Poland. The data were obtained as part of a population based BERCAL (Epidemiologic study of Alzheimer’s diseases and other forms of dementia in the population of Lublin region) study. Odds ratios (ORs) and 95% confidence intervals (CIs) for AD, adjusted for age, were calculated for ApoE genotypes. Epsilon3/epsilon3 genotype was the most prevalent genotype in both examined groups. Epsilon2/epsilon2 and epsilon4/epsilon4 were the least prevalent. Among subjects, the risk of AD was significantly reduced for people with genotypes epsilon2/epsilon2. The same significant result was noticed where results were recalculated so that the presence of at least one epsilon2 allele was taken into account, without any epsilon 4 allele in each person. Increased risk with occurrence of epsilon 4 allele is not shown. Increased risk in epsilon 4 carriers was observed. The test did not reach the level of power required. This study suggests that the well known genetic factor, mainly ApoE, even if of noticeable importance, may not be a main risk factor among the population of the Lublin region in Poland.
REFERENCES(29)
1.
Murayama S, and Saito Y: Neuropathological diagnostic criteria for Alzheimer’s disease. Neuropathology 2004, 24, 254-260.
Muller T, Meyer HE, Egensperger R, Marcus K: The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer’s disease. Prog Neurobiol 2008 Aug, 85(4), 393-406.
Resende R, Ferreiro E, Pereira C, Resende de Oliveira C: Neurotoxic eff ect of oligomeric and fi brillar species of amyloid-beta peptide1-42: involvement of endoplasmic reticulum calcium release in oligomerinduced cell death. Neuroscience 2008 Aug 26, 155(3), 725-737.
Schellenberg GD, Pericak-Vance MA, Wijsman EM, Moore DK, Gaskell PC Jr, Yamaoka LA, Bebout JL, Anderson L, Welsh KA, Clark CM, et al.: Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am J Hum Genet 1991 Mar, 48(3), 563-583.
Roses AD: On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. J Alzheimers Dis 2006, 9(3 Suppl), 361-366.
Riley KP, Snowdon DA, Saunders AM, Roses AD, Mortimer JA, Nanayakkara N: Cognitive function and apolipoprotein E in very old adults: fi ndings from the Nun Study. J Gerontol B Psychol Sci Soc Sci 2000 Mar, 55(2), 69-75.
Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, et al.: Apolipoprotein E associates with beta amyloid peptide of Alzheimer’s disease to form novel monofi brils. Isoform apoE4 associates more effi ciently than apoE3. J Clin Invest 1994 Aug, 94(2), 860-869.
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J,Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993 Mar 1, 90(5), 1977-1981.
Carmo Martins M, Lima Faleiro L, Rodrigues MO, Albergaria I, Fonseca A: Infl uence of the APOE genotypes in some atherosclerotic risk factors. Acta Med Port 2008 Sep-Oct, 21(5), 433-440.
Gustaw K, Woźnica I, Bylina J: ROZPOWSZECHNIENIE ZESPOLOW OTEPIENNYCH W TYM CHOROBY ALZHEIMERA W POPULACJI MIESZKANCOW WOJEWODZTWA LUBELSKIEGO. Medycyna Ogolna 2008, 14 (XLIII), 4, 381-394.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed). American Psychiatric Association 2000. Washington, DC, USA. Text Revision (DSM-IV-TR).
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDSADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 1984, 34, 939-944.
Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplifi cation and cleavage with HhaI.J Lipid Res 1990 Mar, 31(3), 545-548.
Hixson JE, Vernier DT, Powers PK: Detection of SstI restriction site polymorphism in human APOC3 by the polymerase chain reaction. Nucleic Acids Res 1991 Jan 11, 19 (1), 196.
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM: Eff ects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997 Oct 22-29, 278(16), 1349-1356.
The Journal of Pre-Clinical and Clinical Research welcomes article submissions and does not charge a publication fee. Submit your article today and gain worldwide visibility for your article.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.